MDC medlab clinical limited
Add to My Watchlist 0.00% ! $6.60

Medlab Clinical (ASX:MDC) launches cannabis pain treatment...

  1. Herald1337
    471 Posts.
    lightbulb Created with Sketch. 34
    clock Created with Sketch.
    05/02/20
    12:12
    Post #: 42755685

    Medlab Clinical (ASX:MDC) launches cannabis pain treatment trials



    • Medlab Clinical (MDC) has formally launched the NanaBis Observation Study in Australia
    • NanaBis is a cannabis-based pain treatment drug and is also being used to investigate cancer pain management
    • The study is looking to find 2000 patients to help assess the drug over 12 months

    Click to view full article

    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Friday's HotCopper trends: Renascor concentrate, Larvotto raise
right-arrow Created with Sketch.
NEWS Exclusive Pre-IPO & Investment Opportunities in Australia & North America
right-arrow Created with Sketch.
NEWS Renascor produces graphite concentrate at Siviour, right on time to meet ex-China demand
right-arrow Created with Sketch.
NEWS What is going on here? Watch out for DroneShield, Pure Hydrogen, and Nel ASA
right-arrow Created with Sketch.
NEWS Infini remobilising at Portland Creek after geo specialists line up 12 'priority' targets
right-arrow Created with Sketch.
NEWS The 10 hot stocks HotCopper users watchlisted in Week 30
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.